You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

decitabine

Showing 26 - 50 of 220
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Seattle (Decitabine, Ruxolitinib,

Recruiting
  • Acute Myeloid Leukemia
  • +8 more
  • Decitabine
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 18, 2022

Breast Tumor Trial in Shanghai (Decitabine, Carboplatin)

Terminated
  • Breast Neoplasm
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Mar 28, 2022

Acute Myeloid Leukemia Trial in Columbus (Decitabine, Nivolumab, Venetoclax)

Suspended
  • Acute Myeloid Leukemia
  • Decitabine
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Apr 5, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia, Relapsed, Adult Trial in Saint Louis (Decitabine, Bone marrow biopsy/aspirate,

Terminated
Has Results
  • Acute Myeloid Leukemia
  • Acute Myeloid Leukemia, Relapsed, Adult
  • Decitabine
  • +4 more
  • Saint Louis, Missouri
    Washington University School of Medicine
May 9, 2022

Pediatric Acute Myelogenous Leukemia (AML) Trial in Australia, Canada, United States (Decitabine)

Terminated
Has Results
  • Pediatric Acute Myelogenous Leukemia (AML)
  • Decitabine
  • Phoenix, Arizona
  • +21 more
Jun 24, 2022

Relapsed/Refractory Non-Hodgkin Lymphoma, Advanced Solid Tumors Trial in Beijing (Chidamide, Decitabine, Immune checkpoint

Recruiting
  • Relapsed/Refractory Non-Hodgkin Lymphoma
  • Advanced Solid Tumors
  • Beijing, Beijing, China
    Biotherapeutic Department, Chinese PLA General Hospital
Apr 8, 2022

Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myeloblasts 10 Percent or More of Bone Marrow Nucleated Cells Trial in

Recruiting
  • Acute Myeloid Leukemia
  • +7 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
May 16, 2022

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in Worldwide (Decitabine, PDR001, MBG453)

Active, not recruiting
  • Leukemia
  • +7 more
  • Decitabine
  • +3 more
  • Boston, Massachusetts
  • +10 more
Jan 19, 2023

Chronic Myelomonocytic Leukemia, Chronic Myelomonocytic Leukemia-1, Chronic Myelomonocytic Leukemia-2 Trial in Houston

Recruiting
  • Chronic Myelomonocytic Leukemia
  • +3 more
  • Decitabine
  • Tagraxofusp-erzs
  • Houston, Texas
    M D Anderson Cancer Center
Mar 4, 2022

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia Trial in Duarte (Decitabine, Pembrolizumab,

Recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Decitabine
  • +2 more
  • Duarte, California
    City of Hope Comprehensive Cancer Center
Mar 9, 2022

Leukemia Trial in Houston (Vosaroxin, Decitabine)

Completed
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 13, 2022

Previously Treated Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia With

Active, not recruiting
  • Previously Treated Myelodysplastic Syndrome
  • +7 more
  • Decitabine
  • Ipilimumab
  • Duarte, California
  • +10 more
Jul 2, 2022

Myelodysplastic Syndrome, Recurrent Myelodysplastic Syndrome, Refractory Myelodysplastic Syndrome Trial in Philadelphia

Recruiting
  • Myelodysplastic Syndrome
  • +2 more
  • Navitoclax
  • +6 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Feb 2, 2023

Acute Myeloid Leukemia Trial in Shenyang (rhTPO, Decitabine)

Recruiting
  • Acute Myeloid Leukemia
  • Shenyang, Liaoning, China
    ShengJing Hospital of China Medical University
May 16, 2022

Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Canada, United States (CFI-400945, Azacitidine,

Recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Duarte, California
  • +7 more
Jul 20, 2022

Pancreatic Ductal Adenocarcinoma, Sarcoma Trial in Iowa City (Decitabine, Gemcitabine)

Active, not recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Sarcoma
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Dec 3, 2021

Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Buffalo

Active, not recruiting
  • Recurrent Fallopian Tube Carcinoma
  • +2 more
  • Aldesleukin
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Mar 3, 2022

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia Trial in Los Angeles, Sacramento, Oklahoma City (Azacitidine,

Recruiting
  • Acute Myeloid Leukemia
  • Recurrent Acute Myeloid Leukemia
  • Los Angeles, California
  • +2 more
Mar 11, 2022

Solid Tumor Trial in Los Angeles, Baltimore (Decitabine, Cedazuridine)

Recruiting
  • Solid Tumor
  • Los Angeles, California
  • +1 more
Nov 18, 2021

MDS (MDS) Trial (Pevonedistat, Decitabine, Cedazuridine)

Withdrawn
  • Myelodysplastic Syndromes (MDS)
  • (no location specified)
Sep 23, 2021

Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Lymphoblastic Leukemia Trial in

Recruiting
  • Recurrent Acute Lymphoblastic Leukemia
  • +3 more
  • Decitabine
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 29, 2022

MDS, Leukemia, Myelomonocytic, Chronic Trial (decitabine, Spartalizumab, Sabatolimab)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Leukemia, Myelomonocytic, Chronic
  • decitabine
  • +5 more
  • (no location specified)
Aug 5, 2022

Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome Trial in Scottsdale, Cleveland,

Completed
  • Chronic Myelomonocytic Leukemia
  • +3 more
  • Scottsdale, Arizona
  • +3 more
Jan 12, 2023

ACUTE MYELOID LEUKEMIA Trial in New Haven (Glasdegib, Decitabine)

Terminated
Has Results
  • ACUTE MYELOID LEUKEMIA
  • New Haven, Connecticut
    Yale Cancer Center/Smilow
Sep 18, 2021

Acute Myelogenous Leukemia Trial in Boston (decitabine, DC/AML fusion cells)

Recruiting
  • Acute Myelogenous Leukemia
  • decitabine
  • DC/AML fusion cells
  • Boston, Massachusetts
  • +1 more
Nov 15, 2021